Richards Group (RPKIF) reported third-quarter revenue growth of 2%, driven primarily by revenue contributions from the PharmaSystems acquisition. For the quarter ended September 30, 2026, organic Healthcare revenue rose 6.3%, with growth driven by consumables and low-price capital equipment across the Pharmacy and Aesthetic businesses.
Packaging revenue fell 7.3%, compared with a 14.4% decline in the first half, as lower demand continued. Gross margins grew 7%, supported by a stronger healthcare mix. The quarter included a full quarter of the PharmaSystems consumer goods acquisition, completed in May 2026, and the first full year of DermapenWorld ownership. Richards also refinanced bank debt to 2030, increased availability to $150M and repaid $5M.
Richards Group (RPKIF) announced a cash dividend of Cdn$0.11 per share for the month ended October 31, 2026. The dividend is payable on November 13, 2026 to shareholders of record at the close of business on October 30, 2026. Non-resident shareholders may be required to pay withholding taxes on income dividends, whether paid in cash or additional shares.
Richards Group (RPKIF) declared a monthly cash dividend of C$0.11 per share for the month ended September 30, 2026.
The dividend is payable on October 14, 2026 to shareholders of record at the close of business on September 29, 2026. The company notes that non-resident shareholders may be required to pay applicable withholding taxes on dividends, whether received in cash or additional shares.
Richards Group (TSX: RIC, OTC: RPKIF) declared a monthly cash dividend of Cdn$0.11 per share for the month ended August 31, 2026. The dividend is payable on September 14, 2026 to shareholders of record at the close of business on August 31, 2026. Non-resident shareholders may be subject to applicable Canadian withholding tax on these dividends.
Richards Group (TSX: RIC, RPKIF) announced that its Board, following the Audit Committee’s review and recommendation, appointed Ernst & Young LLP as successor auditor, replacing PricewaterhouseCoopers LLP, effective August 10, 2026. The company reported no reservations, modified opinions, or reportable events with the former auditor and has filed the required Notice of Change of Auditor and related letters on SEDAR+.
Richards Group (TSX: RIC, OTC: RPKIF) reported 2026 second quarter results for the period ended June 30, 2026. Total revenue increased 5.2%, primarily from acquisitions including DermapenWorld (June 2025) and PharmaSystems (May 2026). Organic Healthcare revenue rose 7.3%, driven by consumables and low-price capital equipment across the Aesthetic and Pharmacy verticals.
Packaging revenue declined 11.5%, an improvement versus the 17.2% decline in the first quarter and still reflecting macroeconomic conditions. Gross margins increased 18.4%, supported by the recent acquisitions. The company also completed its normal course issuer bid, repurchasing 450,926 shares. Management highlighted progress toward its 2030 Vision, citing continued Healthcare growth, improving margins through customer and product mix, and what it described as an inflection point in earnings and cash flow generation. Full results and a podcast are available on the company’s website and on SEDAR+.
Richards Group (TSX: RIC, OTC: RPKIF) declared a cash dividend of Cdn$0.11 per share for the month ended July 31, 2026. The dividend will be paid on August 14, 2026 to shareholders of record at the close of business on July 31, 2026. Non-resident shareholders may be required to pay applicable Canadian withholding taxes.
Richards Group (TSX: RIC, OTC:RPKIF) declared a monthly cash dividend of Cdn$0.11 per share for the month ended June 30, 2026. Shareholders of record on June 30, 2026 will receive payment on July 14, 2026. Non-resident shareholders may face Canadian withholding tax.
Richards Group (TSX: RIC, OTC: RPKIF) declared a monthly cash dividend of Cdn$0.11 per share for the month ended May 31, 2026. The dividend is payable on June 12, 2026 to shareholders of record as of May 29, 2026.
Non-resident shareholders may be subject to Canadian withholding tax on this dividend.
Richards Group Inc (RPKIF) reported results for the quarter ended March 31, 2026. Q1 saw new OEM product launches under the DermapenWorld brand, healthcare distribution growth, and packaging modernization including ecommerce and a new CRM. US tariffs and higher input and freight costs drove US demand declines and weighed on packaging revenues.
Food & Beverage packaging revenue fell 18% and Cosmetic packaging fell 16%; healthcare OEM and distribution performance showed early strength as investments in marketing and personnel continue.